ACURA PHARMACEUTICALS INC (ACUR)

Overview Price 3.27 Price Change Today +$0.04 (+1.24%) P&P rating Zacks Rank N/A - N/A Open Price $3.25 Previous Close $3.23 Daily Range $3.24 - $3.27 52-Week Range $2.28 - $6.80 Volume 6,262 Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers. Other Resources for ACUR Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Pfizer Makes Milestone Payment July 8, 2011 Zacks Blog: FDA Approves Pfizer/Acura's Oxecta June 23, 2011 Zacks Blog: Company News for June 21, 2011 June 21, 2011 Zacks Blog: Zacks Investment Research: Equity Market Anomalies for June 3, 2011 June 3, 2011 Zacks Blog: Fundamental Anomalies: Debt-to-Equity & Pretax Margin June 2, 2011 Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.   No brokerage coverage for ACUR   ACUR Ratings: BUY  SELL  HOLD ACUR Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 2 Buy 0 Sell   Top Buy Analysis BUY: ACUR Company: ACURA PHARMACEUTICALS INC Points: -101.36 Start Price: $6.95 Start Date: 05/03/2009 2:25 AM mgbigsandco1 P&P Score: 99.37 Recs: No DEBT!!! and a great drug in the pipeline....bought a ton of it at 5 Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
Zacks_Analysts	0.00	07/08/11	Pfizer Makes Milestone Payment - Analyst Blog	0
Zacks_Analysts	0.00	06/23/11	FDA Approves Pfizer/Acura's Oxecta - Analyst Blog	0
Zacks_Analysts	0.00	06/02/11	Fundamental Anomalies: Debt-to-Equity & Pretax Margin - Analyst Blog	0
Zacks_Analysts	0.00	01/24/11	Pfizer Extends King Tender Offer - Analyst Blog	0
Zacks_Analysts	0.00	12/29/10	King Pharma Resubmits Remoxy NDA - Analyst Blog	0
Zacks_Analysts	0.00	12/21/10	King Pharma Files NDA for Pain Drug - Analyst Blog	0
Zacks_Analysts	0.00	04/27/10	Zacks Analyst Blog Highlights: Sprint Nextel, Verizon, AT&T, King Pharmaceuticals, Inc. and Acura Pharmaceuticals, Inc. - Press Releases	0
Zacks_Analysts	0.00	04/26/10	FDA Panel Vote Against Acurox - Analyst Blog	0
Zacks_Analysts	0.00	04/08/10	King Advances Pain Candidate - Analyst Blog	0
Zacks_Analysts	0.00	03/18/10	Acurox to be Reviewed - Analyst Blog	0

Pages: [ 1 ]  2  >>

Commentary

BUY: ACURA PHARMACEUTICALS INC (ACUR) Start Price: $2.69 Points: -1.79 Created: 06/11/2010 pharmacy always good Comments: 0 | Comment Peterjr Recs:

BUY: ACURA PHARMACEUTICALS INC (ACUR) Start Price: $6.95 Points: -101.36 Created: 05/03/2009 No DEBT!!! and a great drug in the pipeline....bought a ton of it at 5 Comments: 0 | Comment mgbigsandco1 Recs:

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
Peterjr	99.06	BUY	Three to Six Months	06/11/2010	$2.69	$3.27 (+1.55%)	+21.56%	+23.35%	-1.79	view close
mgbigsandco1	99.37	BUY	One to Three Months	05/03/2009	$6.95	$3.27 (+1.55%)	-52.95%	+48.41%	-101.36	view close